Skip to main content

Advertisement

Table 1 irAEs frequency and time of onset after IT initiation, considering the MedDRA SOC classification

From: Immunotherapy Bridge 2018 and Melanoma Bridge 2018: meeting abstracts

irAEs Frequency (n = 140) Median time to onset (weeks) Min–max time to onset (weeks)
Gastrointestinal 36 13 1–169
Endocrine 28 19 1–108
Hepatobiliary 19 6 0–30
Respiratory 13 22 1–78
Others 44 16 1–84